S
Serena Tonstad
Researcher at University of Oslo
Publications - 116
Citations - 5372
Serena Tonstad is an academic researcher from University of Oslo. The author has contributed to research in topics: Familial hypercholesterolemia & Metabolic syndrome. The author has an hindex of 31, co-authored 116 publications receiving 4935 citations. Previous affiliations of Serena Tonstad include Oslo University Hospital & Rikshospitalet–Radiumhospitalet.
Papers
More filters
Journal ArticleDOI
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Serena Tonstad,Philip Tønnesen,Peter Hajek,Kathryn E. Williams,Clare B. Billing,Karen R. Reeves +5 more
TL;DR: In this paper, a randomized controlled trial was conducted to determine whether smokers who quit after 12 weeks of treatment with varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, maintain greater continuous abstinence rates (defined as not a single “puff” of a cigarette) than placebo controls.
Journal ArticleDOI
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants
Dagfinn Aune,Dagfinn Aune,Abhijit Sen,Manya Prasad,Teresa Norat,Imre Janszky,Serena Tonstad,Pål Richard Romundstad,Lars J. Vatten +8 more
TL;DR: There was a U shaped association between BMI and mortality in analyses with a greater potential for bias including all participants, current, former, or ever smokers, and in studies with a short duration of follow-up (<5 years or <10 years), or with moderate study quality scores.
Journal ArticleDOI
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
Tuva B. Dahl,A. Yndestad,Mona Skjelland,Erik Øie,Arve Dahl,Annika E. Michelsen,Jan Kristian Damås,Siv H. Tunheim,Thor Ueland,Camilla Smith,Bjørn Bendz,Serena Tonstad,Lars Gullestad,Stig S. Frøland,Kirsten Krohg-Sørensen,David Russell,Pål Aukrust,Bente Halvorsen +17 more
TL;DR: The findings suggest that visfatin should be regarded as an inflammatory mediator, localized to foam cell macrophages within unstable atherosclerotic lesions, that potentially plays a role in plaque destabilization.
Journal ArticleDOI
Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials
Ewelina Rogozińska,Nadine Marlin,Ana Pilar Betrán,Arne Astrup,Annick Bogaerts,José Guilherme Cecatti,Roland Devlieger,Jodie M Dodd,Nermeen Saad El Beltagy,Fabio Facchinetti,Nina Rica Wium Geiker,Kym J. Guelfi,Lene A.H. Haakstad,Cheryce L. Harrison,Hans Hauner,Dorte Møller Jensen,Tarja I. Kinnunen,Janette Khoury,Riitta Luoto,Fionnuala M. McAuliffe,Narges Motahari,Siv Mørkved,Julie A. Owens,Maria Perales,Elisabetta Petrella,Suzanne Phelan,Lucilla Poston,Kathrin Rauh,Kristina M Renault,Linda Reme Sagedal,Kjell Å. Salvesen,Garry X. Shen,Alexis Shub,Tania Scudeller,Fernanda Garanhani Surita,Signe Nilssen Stafne,Helena J. Teede,Serena Tonstad,Mireille N M van Poppel,Christina Anne Vinter,Ingvild Vistad,SeonAe Yeo,Julie Dodds,Sally Kerry,Louise E. Jackson,Pelham Barton,Emma Molyneaux,Alba A Martin,Girish Rayanagoudar,Anneloes E. Ruifrok,Tracy E Roberts,Christianne J.M. de Groot,Arri Coomarasamy,Ben W.J. Mol,Javier Zamora,Khalid S. Khan,Richard D Riley,Shakila Thangaratinam +57 more
TL;DR: The National Institute for Health Research (NIHR) Health Technology Assessment (Health Technology Assessment) program (No as discussed by the authors 12/01/50) was the first one to assess the performance of this approach.
Journal ArticleDOI
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease A Randomized Trial
TL;DR: Varenicline was well tolerated and did not increase cardiovascular events or mortality; however, trial size and duration limit definitive conclusions about safety.